These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists. Mahesh R; Perumal RV; Pandi PV Bioorg Med Chem Lett; 2004 Oct; 14(20):5179-81. PubMed ID: 15380223 [TBL] [Abstract][Full Text] [Related]
6. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity. Dhar AK; Mahesh R; Jindal A; Bhatt S Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677 [TBL] [Abstract][Full Text] [Related]
8. Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives. Wang J; Breslin MJ; Coleman PJ; Duggan ME; Hunt CA; Hutchinson JH; Leu CT; Rodan SB; Rodan GA; Duong LT; Hartman GD Bioorg Med Chem Lett; 2004 Feb; 14(4):1049-52. PubMed ID: 15013021 [TBL] [Abstract][Full Text] [Related]
9. Pyridonecarboxylic acids as antibacterial agents. V. Synthesis of 1-vinyl-1,4-dihydro-4-oxo-1,8- and 1,6-naphthyridine-3-carboxylic acids. Mishio S; Hirose T; Minamida A; Matsumoto J; Minami S Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4402-8. PubMed ID: 4092268 [No Abstract] [Full Text] [Related]
10. Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X. Badawneh M; Ferrarini PL; Calderone V; Manera C; Martinotti E; Mori C; Saccomanni G; Testai L Eur J Med Chem; 2001; 36(11-12):925-34. PubMed ID: 11755235 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives. Mastalarz H; Jasztold-Howorko R; Rulko F; Croisy A; Carrez D Arch Pharm (Weinheim); 2004 Aug; 337(8):434-9. PubMed ID: 15293262 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II. Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines. Saxena AK; Rao J; Chakrabarty R; Saxena M; Srimal RC Bioorg Med Chem Lett; 2007 Mar; 17(6):1708-12. PubMed ID: 17234413 [TBL] [Abstract][Full Text] [Related]
14. Studies on biologically active haloganenated compounds. III. Synthesis and antibacterial activity of 7-fluoromethyl-1,8-naphthyridine and quinoline derivatives. Tani J; Mushika Y; Yamaguchi T Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3517-29. PubMed ID: 7160009 [No Abstract] [Full Text] [Related]
15. Synthesis of antimicrobial agents. VI. Studies on the synthesis of furo[3,2-b][1,8]naphthyridine derivatives. Hayakawa I; Suzuki N; Suzuki K; Tanaka Y Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4914-22. PubMed ID: 6534540 [No Abstract] [Full Text] [Related]
16. [Syntheses of nitrogen-containing heterocyclic compounds. XLIV. Syntheses of 5-substituted 1,6-naphthyridine derivatives using the Reissert compound of 1,6-naphthyridine (author's transl)]. Hamada Y; Shigemura K Yakugaku Zasshi; 1979 Dec; 99(12):1225-8. PubMed ID: 544763 [No Abstract] [Full Text] [Related]
17. 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance. Ruchelman AL; Houghton PJ; Zhou N; Liu A; Liu LF; LaVoie EJ J Med Chem; 2005 Feb; 48(3):792-804. PubMed ID: 15689163 [TBL] [Abstract][Full Text] [Related]